Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response.

Authors

Rachel P. Jackman, Children's National Medical Center, Washington, DC
Xutao Deng, Children's National Medical Center, Washington, DCFollow
Douglas Bolgiano, Children's National Medical Center, Washington, DC
Cathy Schechterly, Children's National Medical Center, Washington, DC
Mila Lebedeva, Children's National Medical Center, Washington, DC
Eva Operskalski, Children's National Medical Center, Washington, DC
Naomi L. Luban, George Washington UniversityFollow
Harvey Alter, Children's National Medical Center, Washington, DC
Michael P. Busch, Children's National Medical Center, Washington, DC
Sherrill J. Slichter, Children's National Medical Center, Washington, DC
Philip J. Norris, Children's National Medical Center, Washington, DC
Garth H. Utter, Children's National Medical Center, Washington, DC

Document Type

Journal Article

Publication Date

3-2014

Journal

Transfusion

Volume

Volume 54, Issue 3

Inclusive Pages

672-680

Keywords

Antibody Formation--physiology; Antibody Formation--radiation effects; Histocompatibility Antigens Class I--immunology; Leukocyte Reduction Procedures; Ultraviolet Rays

Comments

PMCID: PMC3825847 [Available on 2015/3/1]

APA Citation

Jackman, R. P., Deng, X., Bolgiano, D., Utter, G. H., Schechterly, C. et al. (2014). Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response. Transfusion, 54(3), 672-680.

Peer Reviewed

1